Exploratory Analysis of Circulating miR-486-3p and miR-21-5p in Early Detection and Subtype Classification of Luminal A and B Breast Cancer in Peruvian Women

IF 2.5 Q4 ONCOLOGY
Cancer reports Pub Date : 2026-10-09 DOI:10.1002/cnr2.70717
Desireé Bouroncle, Gustavo Colque, Luis Huaytalla-Bautista, María Claudia Flores-Berrospi, Carla Bernal, Ivan Belzusarri, Jorge Dunstan, Mónica Paredes-Anaya
{"title":"Exploratory Analysis of Circulating miR-486-3p and miR-21-5p in Early Detection and Subtype Classification of Luminal A and B Breast Cancer in Peruvian Women","authors":"Desireé Bouroncle,&nbsp;Gustavo Colque,&nbsp;Luis Huaytalla-Bautista,&nbsp;María Claudia Flores-Berrospi,&nbsp;Carla Bernal,&nbsp;Ivan Belzusarri,&nbsp;Jorge Dunstan,&nbsp;Mónica Paredes-Anaya","doi":"10.1002/cnr2.70717","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Breast cancer (BC) remains the most common malignancy among women worldwide, and early detection is essential for improving clinical outcomes. There is a growing need for accessible, minimally invasive molecular biomarkers that complement current diagnostic approaches and support molecular subtype classification.</p>\n </section>\n \n <section>\n \n <h3> Aims</h3>\n \n <p>This exploratory case–control study evaluated the plasma expression of four circulating miRNAs (miR-21-5p, miR-486-3p, miR-451a, and miR-660-5p) in Peruvian women with Luminal A (<i>n</i> = 32) and Luminal B (<i>n</i> = 43) breast cancer and healthy controls (<i>n</i> = 36).</p>\n </section>\n \n <section>\n \n <h3> Methods and Results</h3>\n \n <p>Expression levels were quantified by qPCR, and diagnostic performance was assessed using logistic regression with leave-one-out cross-validation (LOOCV). miR-486-3p was significantly upregulated in Luminal A compared with both controls and Luminal B, whereas miR-21-5p was downregulated relative to controls. After validation, miR-486-3p retained moderate discriminative ability for distinguishing Luminal A from controls (AUC = 0.651; 95% CI: 0.461–0.841; <i>p</i> = 0.120), while the combined miR-486-3p/miR-21-5p model showed moderate discriminatory performance for differentiating Luminal A from Luminal B (AUC = 0.690; 95% CI: 0.466–0.914; <i>p</i> = 0.0959). Exploratory functional enrichment analyses suggested that experimentally validated targets of these miRNAs were associated with cancer- and immune-related pathways, providing biological context for their potential roles in breast cancer.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>These findings provide preliminary evidence supporting the potential of circulating miR-486-3p and miR-21-5p as candidate non-invasive biomarkers for future early detection and molecular subtype classification of Luminal breast cancer. However, these findings should be interpreted cautiously and require validation in larger, independent cohorts before clinical implementation.</p>\n </section>\n </div>","PeriodicalId":9440,"journal":{"name":"Cancer reports","volume":"9 10","pages":""},"PeriodicalIF":2.5000,"publicationDate":"2026-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cnr2.70717","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer reports","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cnr2.70717","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Breast cancer (BC) remains the most common malignancy among women worldwide, and early detection is essential for improving clinical outcomes. There is a growing need for accessible, minimally invasive molecular biomarkers that complement current diagnostic approaches and support molecular subtype classification.

Aims

This exploratory case–control study evaluated the plasma expression of four circulating miRNAs (miR-21-5p, miR-486-3p, miR-451a, and miR-660-5p) in Peruvian women with Luminal A (n = 32) and Luminal B (n = 43) breast cancer and healthy controls (n = 36).

Methods and Results

Expression levels were quantified by qPCR, and diagnostic performance was assessed using logistic regression with leave-one-out cross-validation (LOOCV). miR-486-3p was significantly upregulated in Luminal A compared with both controls and Luminal B, whereas miR-21-5p was downregulated relative to controls. After validation, miR-486-3p retained moderate discriminative ability for distinguishing Luminal A from controls (AUC = 0.651; 95% CI: 0.461–0.841; p = 0.120), while the combined miR-486-3p/miR-21-5p model showed moderate discriminatory performance for differentiating Luminal A from Luminal B (AUC = 0.690; 95% CI: 0.466–0.914; p = 0.0959). Exploratory functional enrichment analyses suggested that experimentally validated targets of these miRNAs were associated with cancer- and immune-related pathways, providing biological context for their potential roles in breast cancer.

Conclusion

These findings provide preliminary evidence supporting the potential of circulating miR-486-3p and miR-21-5p as candidate non-invasive biomarkers for future early detection and molecular subtype classification of Luminal breast cancer. However, these findings should be interpreted cautiously and require validation in larger, independent cohorts before clinical implementation.

循环miR-486-3p和miR-21-5p在秘鲁妇女腔内A、B乳腺癌早期检测和亚型分型中的探索性分析
乳腺癌(BC)仍然是全世界女性中最常见的恶性肿瘤,早期发现对于改善临床结果至关重要。人们越来越需要可获取的、微创的分子生物标志物,以补充当前的诊断方法并支持分子亚型分类。本探索性病例对照研究评估了4种循环mirna (miR-21-5p, miR-486-3p, miR-451a和miR-660-5p)在秘鲁Luminal A (n = 32)和Luminal B (n = 43)乳腺癌妇女和健康对照(n = 36)中的血浆表达。方法与结果采用qPCR定量检测表达水平,采用留一交叉验证(LOOCV)的逻辑回归评估诊断效果。miR-486-3p在Luminal A中与对照组和Luminal B相比均显著上调,而miR-21-5p则相对于对照组下调。经验证,miR-486-3p对Luminal A与对照组的区分能力为中等(AUC = 0.651; 95% CI: 0.461-0.841; p = 0.120),而miR-486-3p/miR-21-5p联合模型对Luminal A与Luminal B的区分能力为中等(AUC = 0.690; 95% CI: 0.466-0.914; p = 0.0959)。探索性功能富集分析表明,实验验证的这些mirna靶点与癌症和免疫相关途径相关,为其在乳腺癌中的潜在作用提供了生物学背景。结论这些发现提供了初步证据,支持循环miR-486-3p和miR-21-5p作为未来早期检测和分子亚型分类的候选非侵入性生物标志物。然而,这些发现应谨慎解释,并在临床实施前需要在更大的独立队列中进行验证。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Cancer reports
Cancer reports Medicine-Oncology
CiteScore
2.70
自引率
5.90%
发文量
160
审稿时长
17 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书